Pacific Biosciences Of California | PACB - Ebitda





Ebitda Veränderung Datum
Agilent USD 456M 84M 2025-12
Bruker USD 143.2M 33.2M 2026-06
Danaher USD 1.84B 81M 2026-06
General Electric Aerospace USD 3.06B 219M 2026-06
Illumina USD 330M 80M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quidel USD 129.3M 20.6M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Standard Biotools USD -8.01M 7.8M 2026-03
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Waters USD 712M 545M 2026-06